CIREX | GBLFX | CIREX / GBLFX | |
Total Expense Ratio | 0.85 | 0.58 | 147% |
Annual Report Gross Expense Ratio | 0.85 | 0.58 | 147% |
Fund Existence | 23 years | 14 years | - |
Gain YTD | 12.928 | 10.242 | 126% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 116B | 28.1B | 413% |
Annual Yield % from dividends | 2.75 | 2.27 | 122% |
Returns for 1 year | 15.44 | 7.99 | 193% |
Returns for 3 years | 34.36 | 31.12 | 110% |
Returns for 5 years | 54.30 | 28.01 | 194% |
Returns for 10 years | 79.69 | 45.82 | 174% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
LABU | 61.54 | 0.84 | +1.38% |
Direxion Daily S&P Biotech Bull 3X ETF | |||
XMAR | 38.38 | 0.06 | +0.17% |
FT Vest U.S. Eq Enh & ModBufETF-Mar | |||
PULS | 49.60 | 0.02 | +0.04% |
PGIM Ultra Short Bond ETF | |||
GJH | 9.34 | N/A | N/A |
Synthetic Fixed-Income Sec STRATS 2004-06 | |||
IBIF | 26.02 | -0.02 | -0.10% |
iShares iBonds Oct 2029 Term Tips ETF |